Jyong Biotech Pre-Tax Profit Margin 1971-1970 | MENS

Jyong Biotech pre-tax profit margin from 1971 to 1970. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue.
Jyong Biotech Pre-Tax Profit Margin Historical Data
Date TTM Revenue TTM Pre-Tax Income Pre-Tax Margin
Sector Industry Market Cap Revenue
Medical MED-BIOMED/GENE $0.722B $0.000B
Jyong Biotech Ltd. is a science-driven biotechnology company. It involved in developing and commercializing new drugs mainly specializing in the treatment of urinary system diseases, with an initial focus on the markets of the U.S., the EU and Asia. Jyong Biotech Ltd. is based in New Taipei City, Taiwan.
Stock Name Country Market Cap PE Ratio
Caris Life Sciences,�Inc (CAI) $6.821B 0.00
Slide Insurance Holdings (SLDE) United States $2.580B 0.00
Flowco Holdings (FLOC) United States $1.616B 0.00
New Providence Acquisition III (NPAC) $0.394B 0.00
Inflection Point Acquisition III (IPCX) $0.351B 0.00
Aduro Clean Technologies (ADUR) Canada $0.273B 0.00
Oaktree Acquisition III Life Sciences (OACC) United States $0.235B 0.00
Range Capital Acquisition (RANG) United States $0.143B 0.00
Tavia Acquisition (TAVI) $0.142B 0.00
YSX Tech (YSXT) China $0.121B 0.00
Youxin Technology (YAAS) China $0.111B 0.00
CO2 Energy Transition (NOEM) United States $0.096B 0.00
Leishen Energy Holding (LSE) China $0.090B 0.00
ChampionsGate Acquisition (CHPG) $0.087B 0.00
YHN Acquisition I (YHNA) $0.082B 0.00
Uni-Fuels Holdings (UFG) $0.069B 0.00
Happy City Holdings (HCHL) $0.036B 0.00
PicoCELA (PCLA) Japan $0.033B 0.00
New Century Logistics (BVI) (NCEW) Hong Kong, SAR China $0.021B 0.00
Hong Kong Pharma Digital Technology Holdings (HKPD) $0.016B 0.00
Sky Quarry (SKYQ) United States $0.014B 0.00